# Trade Mark Journal No.2026/029 17 July 2026

## WO0000001925086 (5)

Office of origin: France

Date of International Registration:23 April 2026
Date of designation in the UK: 23 April 2026

International priority date claimed: 20 April 2026 (France) (5249737)

Class 5
  Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and central nervous system diseases; pharmaceutical preparations for treatment of cancer, thrombosis and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases, particularly lysosomal storage disorders and autosomal dominant polycystic kidney disease; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, bacterial and viral infections.

GENZYME CORPORATION

Representative: Casalonga Caroline CASALONGA, 31 rue de Fleurus, F-75006 Paris, FRANCE